Icon Legend

This session is not in your schedule.

This session is in your schedule. Click again to remove it.

Presentation Icons

Live Streamed

On Demand

274 Views

A4. Treatment of antimicrobial resistant infections

Poster Session: Treatment of Antimicrobial Resistant Infections

(P-1484) In vitro Activity of Cefiderocol and Comparator Agents Against Non-fermentative Gram-negative Bacilli Isolated from Patients Hospitalized with Pneumonia as part of the SENTRY Global Surveillance Program (2020-2022)

Friday, October 18, 2024

12:15 PM – 1:30 PM US PT

Location: Halls JK

Presenting Author(s)

Sean T. Nguyen, PharmD

Director, Medical Affairs
Shionogi Inc.
Florham Park, New Jersey, United States
Boudewijn L. DeJonge, PhD (he/him/his)

Director Microbiology
Shionogi Inc.
Florham Park, New Jersey, United States
CL

Christopher M. Longshaw, PhD

Senior Director, Scientific Affairs EU
Shionogi B.V.
London, England, United Kingdom
Jason J. Bryowsky, PharmD, MS

Director, Field Microbiology
Shionogi Inc.
Florham Park, New Jersey, United States
JM

Joshua Maher, PhD

Element Materials Technology/Jones Microbiology Institute
North Liberty, Iowa, United States
Rodrigo E. Mendes, PhD (he/him/his)

Director of Microbiology & Molecular Biology
JMI Laboratories
North Liberty, Iowa, United States
MT

Miki Takemura, n/a

Director, Head of Infectious Diseases 5, Laboratory for Drug Discovery and Disease Research
Shionogi & Co., Ltd
Toyonaka, Osaka, Japan
Yoshinori Yamano, PhD (he/him/his)

Chief Scientific Officer for Infectious Diseases
Shionogi & Co., Ltd.
Toyonaka, Osaka, Japan